Healthcare Innovations II, 7
Back to All Primary TrustsPortfolio Holdings by Security (As of Deposit Date)
| Ticker | Security Description | Deposit % |
|---|---|---|
| ALKS | ALKERMES PLC | 3.35 |
| ALLO | ALLOGENE THERAPEUTICS INC | 3.35 |
| ALT | ALTIMMUNE INC | 3.39 |
| ANNX | ANNEXON INC | 3.35 |
| ARDX | ARDELYX INC | 3.32 |
| CRMD | CORMEDIX INC | 3.33 |
| CRSP | CRISPR THERAPEUTICS AG | 3.37 |
| FULC | FULCRUM THERAPEUTICS INC | 3.33 |
| GERN | GERON CORP | 3.17 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3.35 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 3.34 |
| KURA | KURA ONCOLOGY INC | 3.37 |
| LRMR | LARIMAR THERAPEUTICS INC | 3.3 |
| LXEO | LEXEO THERAPEUTICS INC | 3.32 |
| NTLA | INTELLIA THERAPEUTICS INC | 3.35 |
| OCGN | OCUGEN INC | 3.32 |
| PCRX | PACIRA BIOSCIENCES INC | 3.24 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 3.40 |
| QURE | UNIQURE NV | 3.39 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3.41 |
| SPRY | ARS PHARMACEUTICALS INC | 3.27 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 3.35 |
| TLX | TELIX PHARMACEUTICALS LTD | 3.34 |
| TVTX | TRAVERE THERAPEUTICS INC | 3.35 |
| URGN | UROGEN PHARMA LTD | 3.28 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3.36 |
| VSTM | VERASTEM INC | 3.32 |
| VTRS | VIATRIS INC | 3.35 |
| ZLAB | ZAI LAB LTD-ADR | 3.28 |
| ZVRA | ZEVRA THERAPEUTICS INC | 3.35 |
Health Care
| Ticker | Security Description | Deposit % |
|---|---|---|
| ALKS | ALKERMES PLC | 3.35 |
| ALLO | ALLOGENE THERAPEUTICS INC | 3.35 |
| ALT | ALTIMMUNE INC | 3.39 |
| ANNX | ANNEXON INC | 3.35 |
| ARDX | ARDELYX INC | 3.32 |
| CRMD | CORMEDIX INC | 3.33 |
| CRSP | CRISPR THERAPEUTICS AG | 3.37 |
| FULC | FULCRUM THERAPEUTICS INC | 3.33 |
| GERN | GERON CORP | 3.17 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3.35 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 3.34 |
| KURA | KURA ONCOLOGY INC | 3.37 |
| LRMR | LARIMAR THERAPEUTICS INC | 3.3 |
| LXEO | LEXEO THERAPEUTICS INC | 3.32 |
| NTLA | INTELLIA THERAPEUTICS INC | 3.35 |
| OCGN | OCUGEN INC | 3.32 |
| PCRX | PACIRA BIOSCIENCES INC | 3.24 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 3.40 |
| QURE | UNIQURE NV | 3.39 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3.41 |
| SPRY | ARS PHARMACEUTICALS INC | 3.27 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 3.35 |
| TLX | TELIX PHARMACEUTICALS LTD | 3.34 |
| TVTX | TRAVERE THERAPEUTICS INC | 3.35 |
| URGN | UROGEN PHARMA LTD | 3.28 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3.36 |
| VSTM | VERASTEM INC | 3.32 |
| VTRS | VIATRIS INC | 3.35 |
| ZLAB | ZAI LAB LTD-ADR | 3.28 |
| ZVRA | ZEVRA THERAPEUTICS INC | 3.35 |
Summary
Description
-
Trust Name Healthcare Innovations II, 7
-
Trust Symbol STHCGX
Deposit Data
-
Deposit Date 05/07/2026
-
Termination Date 05/04/2028
-
Minimum Investment 100
-
Distribution Frequency Monthly (if any)
-
Initial Public Offer Price $10.00
-
Historical 12-Month Dist.* 0
CUSIP
-
Cash Cusip 83208G340
-
Reinvest Cusip 83208G357
-
Fee Cash Cusip 83208G365
-
Fee Invest Cusip 83208G373
Documents
*The Historical 12-Month Distribution of Trust Holdings is as of 07/01/2025. If the Trust deposited after, or 90 days prior to, 07/01/2025, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.